Silo Pharma, Inc.
General ticker "SILO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.3M (TTM average)
Silo Pharma, Inc. does not follow the US Stock Market performance with the rate: -16.0%.
Estimated limits based on current volatility of 3.2%: low 0.45$, high 0.48$
Factors to consider:
- Total employees count: 3 (0.0%) as of 2023
- Top business risk factors: Regulatory and compliance, Product development risks, Economic downturns and volatility, Litigation risks, Cybersecurity threats
- Current price 17.4% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.55$, 1.49$]
- 2025-12-31 to 2026-12-31 estimated range: [0.45$, 1.25$]
Financial Metrics affecting the SILO estimates:
- Positive: with PPE of -0.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -116.49 <= 0.33
- Positive: Shareholder equity ratio, % of 67.92 > 63.39
- Positive: Investing cash flow per share per price, % of 29.59 > -0.66
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of 0 <= 0
Short-term SILO quotes
Long-term SILO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.07MM | $0.07MM | $0.07MM |
| Operating Expenses | $3.70MM | $3.93MM | $4.78MM |
| Operating Income | $-3.63MM | $-3.86MM | $-4.71MM |
| Non-Operating Income | $-0.28MM | $0.22MM | $0.31MM |
| Interest Expense | $0.00MM | $0.00MM | $0.01MM |
| R&D Expense | $1.29MM | $0.85MM | $2.37MM |
| Income(Loss) | $-3.91MM | $-3.63MM | $-4.39MM |
| Other Income(Loss) | $-0.00MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $-3.91MM | $-3.70MM | $-4.39MM |
| Stockholders Equity | $10.34MM | $6.18MM | $5.03MM |
| Assets | $11.64MM | $7.75MM | $7.41MM |
| Operating Cash Flow | $-3.50MM | $-3.22MM | $-3.83MM |
| Investing Cash Flow | $0.09MM | $-4.15MM | $0.97MM |
| Financing Cash Flow | $4.94MM | $-0.47MM | $3.24MM |
| Earnings Per Share** | $-1.71 | $-1.20 | $-1.19 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.